Abcombi Biosciences Inc.
Abcombi Biosciences was formed on June 22nd, 2015 based off of research conducted in the Chemical & Biological Engineering Department at the University at Buffalo. Our corporate headquarters are located in Buffalo, New York in Baird Research Park. Abcombi Biosciences is a pre-clinical vaccine and therapeutic development company dedicated to delivering “smarter” vaccine and anti-infective solutions.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
To accomplish this, we have developed key technologies and analytical strategies to facilitate our unique protection strategies:
- Our novel biofilm model that mimics the natural progression of disease for colonizing bacteria such Streptococcus pneumoniae and Staphylococcus aureus.
- Bioinformatics, in conjunction with our biofilm model, help to identify antigens associated with specific stages of disease progression.
- A novel coupling mechanism that removes the need for complex chemistry to manufacture polysaccharide conjugate vaccines.
- A broad-spectrum RNA-based therapy for treating influenza infections.
At Abcombi, we harness these potent tools to provide universally protective interventions for complex diseases such as pneumonia and influenza.
Core Values
Here at Abcombi, we challenge the status quo both internally and externally in the pursuit of developing patient-oriented solutions to the most pressing problems in infectious disease. We bring our diverse toolsets to bear in the develop potent vaccine and therapeutic indications that achieve superior clinical outcomes.
